HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$36.73
Day range
$35.77 - $38.24
Year range
$8.24 - $47.65
Market cap
2.90B USD
Avg Volume
1.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 41.13M | -31.57% |
Net income | -36.93M | 34.45% |
Net profit margin | — | — |
Earnings per share | -0.52 | 53.98% |
EBITDA | -41.12M | 31.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 593.63M | 125.20% |
Total assets | 599.95M | 123.65% |
Total liabilities | 23.52M | -24.91% |
Total equity | 576.43M | — |
Shares outstanding | 79.14M | — |
Price to book | 5.03 | — |
Return on assets | -21.98% | — |
Return on capital | -23.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -36.93M | 34.45% |
Cash from operations | -28.87M | 42.47% |
Cash from investing | -150.51M | -289.07% |
Cash from financing | 295.19M | 29,518,900.00% |
Net change in cash | 115.81M | 293.67% |
Free cash flow | -14.32M | 50.23% |
About
Founded
2019
Website
Employees
51
